Troponin T level as an exclusion criterion for stem cell transplantation in light-chain amyloidosis.
about
Light chain (AL) amyloidosis: update on diagnosis and managementImmunoglobulin light chain amyloidosis: 2013 update on diagnosis, prognosis, and treatmentImmunoglobulin light chain amyloidosis: 2014 update on diagnosis, prognosis, and treatment.Recent improvements in survival in primary systemic amyloidosis and the importance of an early mortality risk score.High-dose melphalan and peripheral blood stem cell transplantation for light-chain amyloidosis with cardiac involvement.Immunoglobulin light chain amyloidosis: 2011 update on diagnosis, risk-stratification, and management.Role of high-dose melphalan and autologous peripheral blood stem cell transplantation in AL amyloidosis.Light-chain amyloidosis: SCT, novel agents and beyond.Light chain amyloidosis 2012: a new era.Patients with immunoglobulin light chain amyloidosis undergoing autologous stem cell transplantation have superior outcomes compared with patients with multiple myeloma: a retrospective review from a tertiary referral center.Immunoglobulin light chain amyloidosis.Management of systemic AL amyloidosis: recommendations of the Myeloma Foundation of Australia Medical and Scientific Advisory Group.Pathophysiology and treatment of cardiac amyloidosis.Natural history and therapy of AL cardiac amyloidosis.Immunoglobulin light chain amyloidosis: 2016 update on diagnosis, prognosis, and treatment.Long-term outcomes of primary systemic light chain (AL) amyloidosis in patients treated upfront with bortezomib or lenalidomide and the importance of risk adapted strategies.Current treatment of AL amyloidosis.High dose therapy for light chain amyloidosis: can we reduce treatment related mortality further?Auto-SCT improves survival in systemic light chain amyloidosis: a retrospective analysis with 14-year follow-up.Trends in day 100 and 2-year survival after auto-SCT for AL amyloidosis: outcomes before and after 2006.Osteopontin: a novel predictor of survival in patients with systemic light-chain amyloidosis.How to manage primary amyloidosis.Refinement in patient selection to reduce treatment-related mortality from autologous stem cell transplantation in amyloidosis.Induction therapy pre-autologous stem cell transplantation in immunoglobulin light chain amyloidosis: a retrospective evaluation.Trend toward improved day 100 and two-year survival following stem cell transplantation for AL: a comparison before and after 2006.AbstractsPrognosis and risk assessment in AL amyloidosis – state of the art
P2860
Q21198863-054CECF5-8F42-4153-9105-C4CDAA48C466Q26827340-463494A3-B44B-4FFC-84AD-5090569FB51DQ34448455-2456C0D8-BEED-4583-99BA-4B68ECBC6418Q34450910-64F39E9D-6496-48E7-8107-34A3E79FCB67Q35750326-CBE6CDF8-E24D-4B68-AA0F-00838D2E52BFQ37832199-A4D6777D-1471-47A2-99C6-6BB9DC72F3C5Q37995198-81C19131-7284-4FC0-9FD8-DD477500EE6BQ38056010-E8307D97-CB85-48ED-AE6C-7E9233AEECC7Q38072108-4CF62565-E3B6-4D28-A560-453366474315Q38100588-4C1CF662-9A01-404F-972F-6FCBDD65BEF8Q38172295-CCB23DCF-8528-47C5-A940-2BFFF5F371E4Q38244397-CB73C5E7-B56F-4B0B-867E-9D9CFA9F0EF6Q38259728-21C52E4A-1722-4B92-98CB-EED990CCAF46Q38275212-67988C6B-E649-4DBD-B8A9-64AC32FCA667Q38928383-B8F3DC0B-D285-4ADB-9DB3-A43732A9BA6AQ41593651-EA777FFA-ADD8-4F7B-9FFF-8EDA2B3B9800Q42662215-3A8A3139-6270-42E6-B12E-EA7C3DA63534Q43979184-FB52B066-1937-4760-A883-20E651F6AB9FQ44060632-522AB39D-543E-410A-835C-E2258DE3B312Q44468671-3207FA8C-3727-4232-A947-23A158F77D06Q44657473-334EA859-4004-43FB-9252-833C524405D7Q46400142-920F4AA2-EA00-4230-B922-11121FAB1BE9Q48382207-ADE801AC-FA03-48FE-B3EC-7D2A85FADC0AQ51683327-FD13B042-38C5-4EB0-A0D9-B1BFBCC51188Q53226221-10C54E1C-193C-42BB-A6CC-13A361F73E7BQ57259399-171246A0-F36F-4048-B0A2-DB5CB6C2B592Q58176354-C9B6AE85-AC5B-4C54-A55E-C64E9D6AA797
P2860
Troponin T level as an exclusion criterion for stem cell transplantation in light-chain amyloidosis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Troponin T level as an exclusi ...... on in light-chain amyloidosis.
@en
Troponin T level as an exclusi ...... on in light-chain amyloidosis.
@nl
type
label
Troponin T level as an exclusi ...... on in light-chain amyloidosis.
@en
Troponin T level as an exclusi ...... on in light-chain amyloidosis.
@nl
prefLabel
Troponin T level as an exclusi ...... on in light-chain amyloidosis.
@en
Troponin T level as an exclusi ...... on in light-chain amyloidosis.
@nl
P2093
P2860
P50
P1433
P1476
Troponin T level as an exclusi ...... on in light-chain amyloidosis.
@en
P2093
Francis Buadi
Mark Litzow
Shaji Kumar
P2860
P356
10.1080/10428190701684518
P577
2008-01-01T00:00:00Z